Literature DB >> 26699082

Magnesium sulfate protects oligodendrocyte lineage cells in a rat cell-culture model of hypoxic-ischemic injury.

Kanako Itoh1, Takakuni Maki2, Akihiro Shindo2, Naohiro Egawa2, Anna C Liang2, Naoki Itoh2, Eng H Lo2, Josephine Lok1, Ken Arai3.   

Abstract

Hypoxic-ischemic (HI) brain injury in newborns results in serious damage. Magnesium sulfate has been clinically used as a cyto-protective agent against HI brain injury in newborns in some countries, including Japan. However, it is not clear how magnesium exerts this effect and how it acts on the individual types of cells within the newborn brain. In this study, we exposed cultured rat oligodendrocyte precursor cells to magnesium sulfate during the period when they differentiate into oligodendrocytes, and showed that magnesium-exposed oligodendrocytes exhibited more resistance to HI injury. Our data may support the use of magnesium sulfate in the clinical setting.
Copyright © 2015 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Hypoxic–ischemic injury; Magnesium sulfate; Oligodendrocyte; White matter

Mesh：

Substances：

Year:  2015        PMID： 26699082      PMCID： PMC4846506          DOI： 10.1016/j.neures.2015.12.004

Source DB:  PubMed          Journal:  Neurosci Res        ISSN： 0168-0102            Impact factor:   3.304


  18 in total

1.  Antenatal magnesium sulfate and neurodevelopmental outcome of preterm infants born to preeclamptic mothers.

Authors:  Ozlem Bozkurt; Zeynep Eras; Fuat Emre Canpolat; Serife Suna Oguz; Nurdan Uras; Ugur Dilmen
Journal:  J Matern Fetal Neonatal Med       Date:  2015-04-20

Review 2.  The developing oligodendrocyte: key cellular target in brain injury in the premature infant.

Authors:  Joseph J Volpe; Hannah C Kinney; Frances E Jensen; Paul A Rosenberg
Journal:  Int J Dev Neurosci       Date:  2011-03-05       Impact factor: 2.457

3.  Magnesium gates glutamate-activated channels in mouse central neurones.

Authors:  L Nowak; P Bregestovski; P Ascher; A Herbet; A Prochiantz
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

Review 4.  Role of cellular magnesium in health and human disease.

Authors:  Maria José Laires; Cristina Paula Monteiro; Manuel Bicho
Journal:  Front Biosci       Date:  2004-01-01

5.  Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial.

Authors:  Mushtaq Ahmad Bhat; Bashir Ahmad Charoo; Javeed Iqbal Bhat; Sheikh Mushtaq Ahmad; Syed Wajid Ali; Masood-Ul-Hassan Mufti
Journal:  Pediatrics       Date:  2009-04-06       Impact factor: 7.124

6.  Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.

Authors:  Rui Pedro Galvao; Anita Kasina; Robert S McNeill; Jordan E Harbin; Oded Foreman; Roel G W Verhaak; Akiko Nishiyama; C Ryan Miller; Hui Zong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

7.  Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia.

Authors:  Lijuan Han; Wei Cai; Leilei Mao; Jia Liu; Peiying Li; Rehana K Leak; Yun Xu; Xiaoming Hu; Jun Chen
Journal:  Stroke       Date:  2015-08-04       Impact factor: 7.914

8.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

9.  Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.

Authors:  Nobukazu Miyamoto; Takakuni Maki; Akihiro Shindo; Anna C Liang; Mitsuyo Maeda; Naohiro Egawa; Kanako Itoh; Evan K Lo; Josephine Lok; Masafumi Ihara; Ken Arai
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

10.  Magnesium treatment for neuroprotection in ischemic diseases of the brain.

Authors:  Thomas Westermaier; Christian Stetter; Ekkehard Kunze; Nadine Willner; Furat Raslan; Giles H Vince; Ralf-Ingo Ernestus
Journal:  Exp Transl Stroke Med       Date:  2013-04-25
View more
  9 in total

1.  A Novel Three-Dimensional Culture System for Oligodendrocyte Precursor Cells.

Authors:  Naohiro Egawa; Akihiro Shindo; Anna C Liang; Yang Du; Changhong Xing; Evan K Lo; Kanako Itoh; Hisanori Kinoshita; Takakuni Maki; Ryosuke Takahashi; Ryo Sudo; Myron Spector; Josephine Lok; Ken Arai
Journal:  Stem Cells Dev       Date:  2017-05-24       Impact factor: 3.272

2.  Differential roles of epigenetic regulators in the survival and differentiation of oligodendrocyte precursor cells.

Authors:  Naohiro Egawa; Akihiro Shindo; Rie Hikawa; Hisanori Kinoshita; Anna C Liang; Kanako Itoh; Josephine Lok; Takakuni Maki; Ryosuke Takahashi; Eng H Lo; Ken Arai
Journal:  Glia       Date:  2018-11-28       Impact factor: 7.452

3.  High replication stress and limited Rad51-mediated DNA repair capacity, but not oxidative stress, underlie oligodendrocyte precursor cell radiosensitivity.

Authors:  N Daniel Berger; Peter M Brownlee; Myra J Chen; Hali Morrison; Katalin Osz; Nicolas P Ploquin; Jennifer A Chan; Aaron A Goodarzi
Journal:  NAR Cancer       Date:  2022-04-12

4.  Impact of neonatal hypoxia-ischaemia on oligodendrocyte survival, maturation and myelinating potential.

Authors:  Malgorzata Ziemka-Nalecz; Justyna Janowska; Lukasz Strojek; Joanna Jaworska; Teresa Zalewska; Malgorzata Frontczak-Baniewicz; Joanna Sypecka
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

Review 5.  Therapeutic Strategies for Leukodystrophic Disorders Resulting from Perinatal Asphyxia: Focus on Myelinating Oligodendrocytes.

Authors:  Justyna Janowska; Joanna Sypecka
Journal:  Mol Neurobiol       Date:  2017-06-28       Impact factor: 5.590

6.  Magnesium Protects in Episodes of Critical Perfusion after Aneurysmal SAH.

Authors:  Ekkehard Kunze; Nadine Lilla; Christian Stetter; Ralf-Ingo Ernestus; Thomas Westermaier
Journal:  Transl Neurosci       Date:  2018-09-01       Impact factor: 1.757

7.  High Mobility Group A1 Regulates Transcription Levels of Oligodendrocyte Marker Genes in Cultured Oligodendrocyte Precursor Cells.

Authors:  Naohiro Egawa; Gen Hamanaka; Kelly K Chung; Hidehiro Ishikawa; Akihiro Shindo; Takakuni Maki; Ryosuke Takahashi; Haruhisa Inoue; Eng H Lo; Ken Arai
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

Review 8.  Fetal Neuroprotective Strategies: Therapeutic Agents and Their Underlying Synaptic Pathways.

Authors:  Nada A Elsayed; Theresa M Boyer; Irina Burd
Journal:  Front Synaptic Neurosci       Date:  2021-06-23

Review 9.  Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application.

Authors:  Clément Chollat; Loïc Sentilhes; Stéphane Marret
Journal:  Front Neurol       Date:  2018-04-16       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.